(Q37798824)

23 August 2017

Nonalcoholic steatohepatitis: risk factors and diagnosis (English)

1 reference

23 August 2017

0 references

0 references

Leon A Adams

1

1 reference

PubMed ID

20932147

23 August 2017

Ariel E Feldstein

series ordinal

2

1 reference

PubMed ID

20932147

23 August 2017

language of work or name

1 reference

1 October 2010

1 reference

Expert Review of Gastroenterology & Hepatology

23 August 2017

1 reference

23 August 2017

4

1 reference

23 August 2017

5

1 reference

23 August 2017

623-635

1 reference

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

23 August 2017

1 reference

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

21 January 2018

1 reference

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

21 January 2018

1 reference

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients

21 January 2018

1 reference

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

21 January 2018

1 reference

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Noninvasive assessment of hepatic steatosis.

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.

21 January 2018

1 reference

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

Long term prognosis of fatty liver: risk of chronic liver disease and death.

21 January 2018

1 reference

Subacute liver failure in obese women

21 January 2018

1 reference

Nonalcoholic steatohepatitis-related cirrhosis with subacute liver failure: an autopsy case.

21 January 2018

1 reference

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

21 January 2018

1 reference

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?

21 January 2018

1 reference

21 January 2018

1 reference

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

21 January 2018

1 reference

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Outcome after liver transplantation for NASH cirrhosis

21 January 2018

1 reference

Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease

21 January 2018

1 reference

Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies

21 January 2018

1 reference

Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver

21 January 2018

1 reference

Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state.

21 January 2018

1 reference

Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

21 January 2018

1 reference

Hepatic histology in obese patients undergoing bariatric surgery

21 January 2018

1 reference

Subcutaneous and visceral adipose tissue: structural and functional differences

21 January 2018

1 reference

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage

21 January 2018

1 reference

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects

21 January 2018

1 reference

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus

21 January 2018

1 reference

Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.

21 January 2018

1 reference

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

21 January 2018

1 reference

Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.

21 January 2018

1 reference

Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease

21 January 2018

1 reference

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

21 January 2018

1 reference

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

Silent non-alcoholic fatty liver disease-a clinical-histological study

21 January 2018

1 reference

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis

21 January 2018

1 reference

Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women

21 January 2018

1 reference

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

21 January 2018

1 reference

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

21 January 2018

1 reference

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease.

21 January 2018

1 reference

Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment

21 January 2018

1 reference

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

21 January 2018

1 reference

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

21 January 2018

1 reference

Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery

21 January 2018

1 reference

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.

21 January 2018

1 reference

Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease

21 January 2018

1 reference

Adipokines in liver diseases

21 January 2018

1 reference

Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.

21 January 2018

1 reference

Serum chemerin and vaspin in non-alcoholic fatty liver disease

21 January 2018

1 reference

Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

21 January 2018

1 reference

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Pathogenesis of non-alcoholic steatohepatitis: human data

21 January 2018

1 reference

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease

21 January 2018

1 reference

Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

21 January 2018

1 reference

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients

21 January 2018

1 reference

A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients

21 January 2018

1 reference

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

A "biomarker biopsy" for the diagnosis of NASH: promises from CK-18 fragments.

21 January 2018

1 reference

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

21 January 2018

1 reference

Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?

21 January 2018

1 reference

Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits

21 January 2018

1 reference

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.10.56

1 reference

23 August 2017

1 reference

PubMed ID

20932147